Partners Brett Schuman and Bill Growney outline factors private equity and venture capital firms should consider when evaluating a startup or emerging business in the cannabis industry.
Read the full article.
Related Content
- AlertNovember 8, 2023
Another Domino Falls: Ohio Voters Legalize Adult-Use Cannabis
- AlertAugust 31, 2023
Department of Health and Human Services Recommends that Cannabis be Rescheduled as a Schedule III Drug Under the Controlled Substances Act
- AlertMay 30, 2023
A Mini-Green Wave? Two More States Legalize Adult-Use Cannabis
- AlertMay 16, 2023
New York Releases Significant Changes to Adult-Use Cannabis Regulations
- In the PressJanuary 27, 2023
Cannabis Marketing Proposed Regulations in New York & Neighboring States (Bloomberg Law)
- AlertNovember 9, 2022
No Green Wave This Time, But Two More States Legalize Adult-Use Cannabis
- AlertOctober 10, 2022
President Biden Announces a Three-Step Approach to Cannabis Reform: Federal Pardons, an Appeal to the States, and a Review of Cannabis Classification Under the Controlled Substances Act
- AlertMay 31, 2022
Florida’s Telephone Solicitation Act Survives First Constitutional Challenge
- Awards and RankingsOctober 3, 2023
Elaine Blais and Brett Schuman Named 2023 Law360 MVPs
- In the PressAugust 30, 2023
California Supreme Court Review: August 2023 (Daily Journal)
- Awards and RankingsJune 22, 2023
Jennifer Fisher Named to Daily Journal’s Top Women Lawyers 2023
- Awards and RankingsJune 13, 2023
The Legal 500 United States 2023 Recognizes Goodwin Lawyers and Practices Nationwide
- Awards and RankingsMay 18, 2023
Brett Schuman and Neel Chatterjee Named to Daily Journal’s Top IP Lawyers 2023
- In the PressApril 21, 2023
Interstate Cannabis Commerce May Be In Reach, With Caveats (Law360)
- In the PressApril 19, 2023
From High Stakes to High Investments: Navigating Cannabis Law with Jennifer Fisher (Proud To Work In Cannabis)
- In the PressMarch 30, 2023
Jennifer Fisher & Bill Growney (Psychedelic Capital Podcast)